|
WDSUB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.179700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.212400E-01 |
| Normal-vs-Stage2 |
6.055800E-02 |
| Normal-vs-Stage3 |
3.526000E-02 |
| Normal-vs-Stage4 |
1.464640E-01 |
| Stage1-vs-Stage2 |
1.809410E-01 |
| Stage1-vs-Stage3 |
1.691380E-01 |
| Stage1-vs-Stage4 |
5.440200E-01 |
| Stage2-vs-Stage3 |
7.838400E-01 |
| Stage2-vs-Stage4 |
5.507400E-01 |
| Stage3-vs-Stage4 |
6.844400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.455600E-02 |
| Normal-vs-AfricanAmerican |
8.359600E-01 |
| Normal-vs-Asian |
9.233600E-01 |
| Caucasian-vs-AfricanAmerican |
1.180630E-01 |
| Caucasian-vs-Asian |
9.084100E-02 |
| AfricanAmerican-vs-Asian |
7.790200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.347800E-02 |
| Normal-vs-Female |
1.140830E-01 |
| Male-vs-Female |
3.469200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.377400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.216000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.141780E-02 |
| Normal-vs-Age(81-100Yrs) |
4.164900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.042800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.213500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.753700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.898250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.763500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.679200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.421200E-01 |
| Classical-VS-Follicular |
7.773600E-01 |
| Classical-VS-Other |
8.857800E-01 |
| Classical-VS-Normal |
2.073000E-01 |
| Tall-VS-Follicular |
9.462400E-01 |
| Tall-VS-Other |
9.800200E-01 |
| Tall-VS-Normal |
2.077200E-01 |
| Follicular-VS-Other |
9.912400E-01 |
| Follicular-VS-Normal |
2.281600E-01 |
| Other-VS-Normal |
4.687600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.180500E-02 |
| Normal-vs-N1 |
8.895900E-02 |
| N0-vs-N1 |
9.992000E-01 |
|
|
